|
CEP70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.393600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.081400E-01 |
| Normal-vs-Stage2 |
9.555600E-02 |
| Normal-vs-Stage3 |
2.936000E-01 |
| Normal-vs-Stage4 |
3.610400E-01 |
| Stage1-vs-Stage2 |
2.262000E-02 |
| Stage1-vs-Stage3 |
9.384100E-02 |
| Stage1-vs-Stage4 |
3.665200E-01 |
| Stage2-vs-Stage3 |
8.382400E-01 |
| Stage2-vs-Stage4 |
3.481600E-01 |
| Stage3-vs-Stage4 |
3.505200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.313800E-01 |
| Normal-vs-AfricanAmerican |
5.911200E-01 |
| Normal-vs-Asian |
8.805800E-02 |
| Caucasian-vs-AfricanAmerican |
1.924980E-01 |
| Caucasian-vs-Asian |
8.522200E-02 |
| AfricanAmerican-vs-Asian |
3.083200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.180800E-01 |
| Normal-vs-Female |
5.629000E-01 |
| Male-vs-Female |
1.765560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.915700E-02 |
| Normal-vs-Extreme_Weight |
5.866400E-01 |
| Normal-vs-Obese |
4.544000E-01 |
| Normal-vs-Extreme_Obese |
6.853200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.294200E-02 |
| Normal_Weight-vs-Obese |
6.572300E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.476600E-01 |
| Extreme_Weight-vs-Obese |
8.081000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.133200E-01 |
| Obese-vs-Extreme_Obese |
5.482000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.897000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.351800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.263200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.238200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.833980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.599990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.377800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.586000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.216160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.377500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.543800E-03 |
| Normal-VS-Type2 PRCC |
4.926200E-01 |
| Normal-VS-KIRP CIMP |
4.045700E-02 |
| Normal-VS-Unclassified PRCC |
2.522200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.278600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.626000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.498600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.763200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.008600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.489600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.757600E-01 |
| Normal-vs-N1 |
1.622230E-01 |
| Normal-vs-N2 |
1.841770E-03 |
| N0-vs-N1 |
3.267200E-01 |
| N0-vs-N2 |
2.070600E-01 |
| N1-vs-N2 |
6.756100E-02 |
|
|
